[ Price : $8.95]
FDA posts a guidance on Recurrent Herpes Labialis: Developing Drugs for Treatment and Prevention that discusses the overall develo...[ Price : $8.95]
Federal Register proposed order: FDA proposes to reclassify the needle destruction device, renaming the device to sharps needle de...[ Price : $8.95]
Sen. Kamela Harris says she is investigating efforts by Alkermes to artificially boost sales of its Vivitrol opioid addiction trea...[ Price : $8.95]
Federal Register notice: FDA classifies the total 25-hydroxyvitamin D mass spectrometry test system into Class 2 (special controls...[ Price : $8.95]
Federal Register final order: FDA exempts from premarket notification requirements autosomal recessive carrier screening gene muta...[ Price : $8.95]
FDA denies a Millennial Pharmaceuticals petition seeking to put limits on ANDA or 505(b)(2) applications referencing its Velcade.[ Price : $8.95]
FDA Oncology Center of Excellence staffers say they are optimistic about the future of oncology drug development after approving t...[ Price : $8.95]
FDA lifts its clinical hold on a Cellectis investigational cancer drugs Phase 1 trials.